Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
RECRUITING
NA
160 participants
INTERVENTIONAL
2022-10-03
2026-05-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Eligible Veteran participants will be randomized to ERP or to the control condition. Veterans randomized to ERP will receive 16 weekly ERP sessions delivered via VTH. Control participants will receive 16 weekly sessions of a stress management training intervention delivered via VTH. Participants in both conditions will complete assessments at post-treatment and 6 months after completing treatment. Participants in the ERP condition will also complete an assessment of treatment satisfaction and a qualitative exit interview assessing the Veterans' perceptions of the impact of treatment on multiple domains of functioning, including the impact on PTSD symptoms. Providers and VA administrators will participate in qualitative interviews regarding the implementation potential of ERP in VA.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Keywords
Explore important study keywords that can help with search, categorization, and topic discovery.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exposure and Response Prevention (ERP)
ERP will be based upon the Treatments That Work series, which contains both a provider manual and client workbook. Sessions will last 90 minutes and occur weekly for 16 sessions. All ERP treatment will be delivered via VTH. Participants will receive instructions on accessing the VTH platform and take part in a brief practice run connecting to the VTH appointment with guidance from an RA. ERP treatment content includes psychoeducation about OCD, assessment of OCD symptoms, the rationale for treatment, construction of a hierarchy or a list of feared or avoided situations, and in-session in-vivo and imaginal exposures. Weekly homework assignments will include self-monitoring, reading chapters about the treatment, and practicing exposures daily. All therapy sessions will be audio-recorded. Although sessions are expected to occur weekly, accounting for delays due to scheduling, holidays, and missed appointments, the investigators will allow up to 6 months to complete the treatment.
Exposure and Response Prevention
ERP is a specialized cognitive behavioral intervention conducted over the course of 8-16 therapy sessions. ERP is based upon exposure principles and the idea that people can habituate to the distress caused by OCD triggers and learn to cope with anxiety about feared consequences without engaging in compulsive behaviors to 'neutralize' the obsession. ERP begins with psychoeducation about OCD and exposure, followed by construction of a hierarchy, or list, of situations that are feared, avoided, or trigger OCD rituals such as washing or checking. Then, the therapist and client begin in-session exposures to hierarchy items utilizing response or ritual prevention techniques to avoid reinforcing the ritual. Exposures can be in vivo, such as touching a contaminated item, or imaginal, such as visualizing a feared consequence happening.
Control Condition
Participants randomized to the control condition will receive 16 weekly sessions of stress management training via video telehealth. This control condition was chosen because it is expected to provide the therapeutic alliance and common factors associated with therapy generally and some specific effects in anxiety reduction.
Stress Management Training
The stress management training intervention will be based on that delivered by Simpson in an ERP trial. It will be delivered by PhD and Master's level therapists from each site's clinics. The stress management training intervention will begin with an introductory session providing psychoeducation about OCD, followed by 15 sessions covering stress management skills such as deep breathing progressive muscle relaxation, positive imagery, assertiveness training, and problem solving. Each session will contain an extended practice of the selected skill and will end with homework assignments to practice the stress management skills and monitor symptoms.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exposure and Response Prevention
ERP is a specialized cognitive behavioral intervention conducted over the course of 8-16 therapy sessions. ERP is based upon exposure principles and the idea that people can habituate to the distress caused by OCD triggers and learn to cope with anxiety about feared consequences without engaging in compulsive behaviors to 'neutralize' the obsession. ERP begins with psychoeducation about OCD and exposure, followed by construction of a hierarchy, or list, of situations that are feared, avoided, or trigger OCD rituals such as washing or checking. Then, the therapist and client begin in-session exposures to hierarchy items utilizing response or ritual prevention techniques to avoid reinforcing the ritual. Exposures can be in vivo, such as touching a contaminated item, or imaginal, such as visualizing a feared consequence happening.
Stress Management Training
The stress management training intervention will be based on that delivered by Simpson in an ERP trial. It will be delivered by PhD and Master's level therapists from each site's clinics. The stress management training intervention will begin with an introductory session providing psychoeducation about OCD, followed by 15 sessions covering stress management skills such as deep breathing progressive muscle relaxation, positive imagery, assertiveness training, and problem solving. Each session will contain an extended practice of the selected skill and will end with homework assignments to practice the stress management skills and monitor symptoms.
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willingness to participate in Exposure and Response Prevention(ERP)
Exclusion Criteria
* Potential participants taking psychotropic medications must be on a stable dose of these medications for at least 6 weeks prior to study enrollment.
18 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
VA Office of Research and Development
FED
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Terri L. Fletcher, PhD
Role: PRINCIPAL_INVESTIGATOR
Michael E. DeBakey VA Medical Center, Houston, TX
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
East Orange Campus of the VA New Jersey Health Care System, East Orange, NJ
East Orange, New Jersey, United States
VA Western New York Healthcare System, Buffalo, NY
Buffalo, New York, United States
VA NY Harbor Healthcare System, New York, NY
New York, New York, United States
Northport VA Medical Center, Northport, NY
Northport, New York, United States
James J. Peters VA Medical Center, Bronx, NY
The Bronx, New York, United States
Asheville VA Medical Center, Asheville, NC
Asheville, North Carolina, United States
Durham VA Medical Center, Durham, NC
Durham, North Carolina, United States
Fayetteville VA Medical Center, Fayetteville, NC
Fayetteville, North Carolina, United States
Salisbury W.G. (Bill) Hefner VA Medical Center, Salisbury, NC
Salisbury, North Carolina, United States
VA Roseburg Healthcare System, Roseburg, OR
Roseburg, Oregon, United States
VA Southern Oregon Rehabilitation Center and Clinics, White City, OR
White City, Oregon, United States
Ralph H. Johnson VA Medical Center, Charleston, SC
Charleston, South Carolina, United States
Michael E. DeBakey VA Medical Center, Houston, TX
Houston, Texas, United States
Hampton VA Medical Center, Hampton, VA
Hampton, Virginia, United States
Hunter Holmes McGuire VA Medical Center, Richmond, VA
Richmond, Virginia, United States
Salem VA Medical Center, Salem, VA
Salem, Virginia, United States
Spokane VA Medical Center, Spokane, WA
Spokane, Washington, United States
Jonathan M. Wainwright Memorial VA Medical Center, Walla Walla, WA
Walla Walla, Washington, United States
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Jennifer Schneider, PhD
Role: primary
Matthew G Escamilla, BS
Role: backup
Jennifer Schneider, PhD
Role: primary
Matthew G Escamilla, BS
Role: backup
Jennifer Schneider, PhD
Role: primary
Matthew, BS
Role: backup
Jennifer Schneider, PhD
Role: primary
Matthew Escamilla, BS
Role: backup
Jennifer Schneider, PhD
Role: primary
Matthew G Escamilla, BS
Role: backup
Holly Hunley, PhD
Role: primary
Matthew G Escamilla, BS
Role: backup
Holly Hunley, PhD
Role: primary
Matthew G Escamilla, BS
Role: backup
Holly Hunley, PhD
Role: primary
Matthew G Escamilla, BS
Role: backup
Holly Hunley, PhD
Role: primary
Matthew G Escamilla, BS
Role: backup
Milena S Roussev, PhD
Role: primary
Matthew G Escamilla, BS
Role: backup
Milena S Roussev, PhD
Role: primary
Matthew G Escamilla, BS
Role: backup
Ursula S Myers, PhD
Role: primary
Matthew G Escamilla, BS
Role: backup
Matthew G Escamilla, BS
Role: primary
Holly Hunley, PhD
Role: primary
Matthew G Escamilla, BS
Role: backup
Holly Hunley, PhD
Role: primary
Matthew Escamilla, BS
Role: backup
Holly Hunley, PhD
Role: primary
Matthew G Escamilla, BS
Role: backup
Milena S Roussev, PhD
Role: primary
Matthew G Escamilla, BS
Role: backup
Milena S Roussev, PhD
Role: primary
Matthew G Escamilla, BS
Role: backup
References
Explore related publications, articles, or registry entries linked to this study.
Ponzini GT, Hundt NE, Christie IC, Chen PV, Ecker AH, Lindsay JA, Teng EJ, Storch EA, Myers US, Roussev MS, Fletcher TL. A protocol for a randomized controlled trial of exposure and response prevention for veterans with obsessive compulsive disorder. Contemp Clin Trials. 2024 Mar;138:107445. doi: 10.1016/j.cct.2024.107445. Epub 2024 Jan 17.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
D3677-R
Identifier Type: -
Identifier Source: org_study_id